BioSpace News Archive

U.K. retrospective chart review examined potential predictors of treatment response including age, baseline AKI severity and concomitant use of albumin in patients with HRS-AKI

Iterum Therapeutics plc, a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, reported financial results for the third quarter ended September 30, 2020.

Net proceeds of approximately $440 million raised from completed business combination transaction with ARYA Sciences Acquisition Corp II and concurrent PIPE financing

Nordic Nanovector ASA announces that its Interim CEO, Dr Lars Nieba will present a corporate overview, via live webcast, and host one-on-one meetings with investors at the Jefferies Virtual London Healthcare Conference, taking place 17-19 November 2020.

Guardant Health, Inc. announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal amount of convertible senior notes due 2027 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

Apellis Pharmaceuticals, Inc., a global biopharmaceutical company and leader in targeted C3 therapies, announced that the U.S. Food and Drug Administration has accepted and granted Priority Review designation for the New Drug Application for pegcetacoplan for the treatment of paroxysmal nocturnal hemoglobinuria.

Results support advancement into Phase 2 combination clinical trialswith AB-729 dosing as infrequently as every 8 or 12 weeks

Presentation featured at The Liver Meeting® 2020, the AASLD Annual Meeting, details support for the design of phage therapy candidate BX003

Advancing American kidney health has been identified as a key public health priority by a 2019 Presidential Executive Order

Phase 3 studies for diabetic macular edema and retinal vein occlusion enrolling well and on track for topline results also in 2022